Conference Coverage

Air pollution contribution to lung cancer may be underestimated


 

FROM WCLC

Lung cancer in female nonsmokers

During the oral abstract session, invited discussant Chang-Chuan Chan, ScD, National Taiwan University, Taipei, said that the study’s focus on female patients with lung cancer is important. He pointed to a 2019 study examining the relationship between air pollution and lung cancer among nonsmokers in Taiwan, in which the authors found that, although smoking levels among women remained low over time (about 5%), the incidence of lung adenocarcinomas among women increased from 7.05 per 100,000 in 1995, to 24.22 per 100,000 in 2015.

The authors of that study also found that changes in PM2.5 levels in Taiwan were predictive of fluctuations in lung cancer prevalence in never-smokers.

“We’re moving from 50-year studies of smoking to these new issues of air pollution, asbestos, and radon, and I think it’s better that these three factors can be combined together,” he said at the meeting sponsored by the International Association for the Study of Lung Cancer.

The study was supported by the BC Cancer Foundation, Terry Fox Research Institute, and VGH-UBC Hospital Foundation. Dr. Myers and Dr. Chan reported having no financial conflicts of interest to disclose.

Pages

Recommended Reading

Additional postoperative radiotherapy prolongs survival in stage I-IIA SCLC
MDedge Hematology and Oncology
NSCLC: Meta-analysis cautions concomitant use of gastric acid suppressants and immunotherapy
MDedge Hematology and Oncology
NSCLC: rhG-CSF tied to increased metastasis risk following postoperative chemotherapy
MDedge Hematology and Oncology
Concurrent ADT for prostate cancer improves survival in subsequently diagnosed lung cancer
MDedge Hematology and Oncology
Network meta-analysis evaluates optimal postoperative chemotherapy in early resected NSCLC
MDedge Hematology and Oncology
Airflow limitation tied to increased risk for lung cancer
MDedge Hematology and Oncology
Incidence of checkpoint inhibitor-related myocarditis in lung cancer patients
MDedge Hematology and Oncology
One in four NSCLC patients respond poorly to COVID-19 vaccine
MDedge Hematology and Oncology
CV admissions on the rise in Americans with cancer
MDedge Hematology and Oncology
Smoking cessation with lung screening ups quit rates
MDedge Hematology and Oncology